Clinical Trials Directory

Trials / Completed

CompletedNCT03137797

Cohort of Patients Naive of Antiretroviral Treatment at Enrollment

Status
Completed
Phase
Study type
Observational
Enrollment
800 (actual)
Sponsor
ANRS, Emerging Infectious Diseases · Other Government
Sex
All
Age
15 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the short, medium and long-term prognosis for newly diagnosed HIV patients.

Detailed description

The purpose of this study is to evaluate the short, medium and long-term prognosis for newly diagnosed HIV patients. This study aims to precise the impact of HIV infection treatment on morbidity and mortality, the factors related to treatment response, clinical and biological complications, their consequences, especially lipodystrophy and metabolic abnormalities, associated factors especially genetic, aspects linked to aging. In addition, the study describes the evolution of patients living conditions and behaviors remotely from their screening, particularly related to sexuality, reproduction, and health inequalities and to study the long-term treatment adherence. One third of the patients were included in the metabolic disorders module. This module includes additional biological and imaging explorations.

Conditions

Timeline

Start date
2004-02-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2017-05-03
Last updated
2017-05-03

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03137797. Inclusion in this directory is not an endorsement.